Search results
Feb 12, 2024 · He qualified from the University of Edinburgh (UK) summa cum laude in Pharmacology in 1985 and in Medicine in 1988 where he was the Brunton Medalist. As a Carnegie scholar at the University of California, San Diego (CA, USA) he saw the early promise of angioplasty and changed his career plan from cardiac surgery to coronary intervention.
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet (London, England) 2018 | Journal article. DOI: 10.1016/s0140-6736 (17)32458-3. Part of ISSN: 0140-6736.
Jun 16, 2017 · Dr Derek Connolly speaks to Adam Price-Evans, Commissioning Editor of Future Cardiology: Derek Leslie Connolly is a Consultant Interventional Cardiologist at Birmingham City Hospital (UK). He qualified from the University of Edinburgh (UK) summa cum laude in Pharmacology in 1985 and in Medicine in 1988 where he was the Brunton Medalist.
- Derek Leslie Connolly
- 2017
Consultant Cardiologist. Professor Derek Connolly is a Consultant Interventional Cardiologist and the Director of Research and Development at Birmingham City Hospital. He is an Honorary Senior Clinical Lecturer at the Institute of Cardiovascular Sciences, University of Birmingham, UK.
Jan 1, 2023 · Seventeen University of Chicago faculty members have received distinguished service professorships or named professorships. Profs. Fernando Alvarez, Diane Lauderdale, Jeffrey Matthews, Magne Mogstad, Mark Payne, Douglas Skinner, Marsha Rosner, Matthew Tirrell and Everett Vokes have been named distinguished service professors.
Dr Derek Connolly is a Consultant Cardiologist and the Director of Research and Development at Birmingham City Hospital. He is an Honorary Senior Clinical Lecturer at the Institute of Cardiovascular Sciences, University of Birmingham, UK. He is Clinical Lead for Cardiac Care for BCICS.
His PhD in molecular cardiology is from the University of Cambridge. He was awarded an honorary DSc by Aston University. He is the Chief or Primary Investigator of multiple large trials in Cardiovascular medicine.
